Related Experiment Video
Updated: Aug 19, 2026

Peptide-based Identification of Functional Motifs and their Binding Partners
Published on: June 30, 2013
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease
A J McNeil1, P L Yap, S M Gore
1Department of Applied Mathematics, University of Zurich, Switzerland.
Insights
Human Leukocyte Antigen (HLA) types A1-B8-DR3 and B27 impact Human Immunodeficiency Virus (HIV) disease progression. HLA A1-B8-DR3 is linked to faster disease progression and CD4+ T-cell loss in HIV patients.
Area of Science:
- Immunogenetics
- Virology
- Clinical Medicine
Background:
- Human Leukocyte Antigen (HLA) genes play a crucial role in immune response and disease susceptibility.
- Specific HLA types have been associated with varying rates of Human Immunodeficiency Virus (HIV) infection progression.
- Understanding these associations can inform prognostic assessments and potential therapeutic strategies.
Purpose of the Study:
- To investigate the relationship between specific HLA types (A1-B8-DR3 and B27) and the clinical progression of HIV disease.
- To determine the association of these HLA types with the rate of CD4+ lymphocyte count decline in HIV-positive individuals.
- To analyze the impact of HLA A1-B8-DR3 and B27 on progression to Centers for Disease Control and Prevention (CDC) stage IV, Acquired Immunodeficiency Syndrome (AIDS), and mortality.
Main Methods:
- Prospective cohort study of 692 HIV-positive patients from 1985 to 1994.
- Retrospective determination of seroconversion times for a subgroup of 313 patients.
- HLA typing performed on 262 patients; proportional hazards analysis and random effects growth curve models used for statistical analysis of disease progression and CD4+ cell count changes.
Main Results:
- HLA type A1-B8-DR3 was significantly associated with increased relative risks for progression to CDC stage IV (1.9-fold), AIDS (3.1-fold), and death (3.7-fold) after HIV seroconversion.
- Patients with HLA A1-B8-DR3 exhibited a more rapid loss of CD4+ T-cell count and CD4+ percentage.
- HLA type B27 was associated with slower progression to CDC stage IV (0.3-fold) and slower loss of CD4+ markers, though events for B27 were too rare for mortality and AIDS analyses.
Conclusions:
- Specific HLA genotypes, particularly A1-B8-DR3, are strong predictors of more rapid HIV disease progression and immune deterioration.
- HLA type B27 appears to be associated with a slower disease course in HIV infection.
- These findings highlight the influence of host genetics, specifically HLA type, on the clinical trajectory of HIV/AIDS.
Abstract:
We examined how HLA types A1-B8-DR3 and B27 were related to progression of clinical disease and rate of loss of CD4 lymphocytes in the Edinburgh City Hospital cohort of HIV-positive patients, mainly injection drug users. Patients (n = 692) were prospectively followed from 1985 through March 1994. Accurately estimated seroconversion times were determined retrospectively for a subgroup of 313 (45%). Of 262 patients (39%) who were fully or partially HLA typed, 155 (50%) had known seroconversions. Of 34 patients typed positive for A1-B8-DR3, 29 progressed to CDC stage IV, 22 to AIDS and 20 died. Twelve patients were typed positive for B27; six of these progressed to CDC stage IV, one to AIDS and none died. In a proportional hazards analysis of the 313 patients with known seroconversions, A1-B8-DR3 was significantly associated with covariate-adjusted relative risks of 3.7 (95% CI 1.9-7.2), 3.1 (1.6-6.0) and 1.9 (1.1-3.2) for progression from seroconversion to death, AIDS and CDC stage IV, respectively. Events for B27 were too rare to include B27 in analyses to death and AIDS, but B27 was significantly associated with slower progression to CDC stage IV (0.3, CI 0.1-0.9). Random effects growth curve models were used to estimate individual rates of loss of square root CD4 count and loss of CD4 percentage, for 603 and 617 patients, respectively. A1-B8-DR3 was associated with rapid loss of both markers (p = 0.02 and p = 0.01, respectively); B27 was associated with slow loss of both markers (p = 0.04 and p < 0.005).
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Cryptococcal Meningitis

